Načítá se...

Genetic biomarkers predict response to dual BCL-2 and MCL-1 targeting in acute myeloid leukaemia cells

Acute myeloid leukaemia (AML) cells often up-regulate pro-survival members of the BCL-2 protein family, such as BCL-2 and MCL-1, to avoid apoptosis. Venetoclax (ABT-199) targets BCL-2 and has shown promising efficacy in AML but over-expression of MCL-1 can cause resistance. A co-operative approach,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Grundy, Martin, Balakrishnan, Sahana, Fox, Matthew, Seedhouse, Claire H., Russell, Nigel H.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6340871/
https://ncbi.nlm.nih.gov/pubmed/30701031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26540
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!